Institute of Clinical Medicine - News

A team of researchers at the University of Eastern Finland and Kuopio University Hospital explores the commercialisation of a hearing rehabilitation innovation.

Neurons produced from frontotemporal dementia patients’ skin biopsies using modern stem cell technology recapitulate the synaptic loss and dysfunction detected in the patients’ brains.

NSAID-exacerbated respiratory disease, N-ERD, is associated with measurable changes in concentrations of lipid mediators involved in inflammation and pain modulation, a new study shows.

Low labour market participation for non-retirement related reasons may be an early indicator of dementia already years before the first evident symptoms occur. Other erly social of dementia were also identified.

A new study explored who are most likely to adopt and actively use digital well-being apps in North Savo, finding that app engagement was, ultimately, most active among those with highest life satisfaction.

A randomised placebo-controlled Finnish study showed that aspirin therapy does not provide significant relief for people suffering from chronic rhinosinusitis with nasal polyps who are hypersensitive to non-steroidal anti-inflammatory drugs (NSAIDs).

The fluorescence-based tissue monitoring device enables safe and efficient brain tumour detection.

“Investing in hearing care can also help prevent memory disorders,” Professor Aarno Dietz pointed out in a workshop organised by the Hearing Valley project and the UEF Brain Research Unit.

Automated insulin delivery pumps significantly improved quality of life and reduced diabetes-related complications.

Finland remains a world-leader in neonatal care, despite the country’s falling birth rate and, consequently, a decline in hospital delivery volumes.